The effectiveness of expanded neonatal screening in the Penza Region in 2023–2024

Neonatal screening is a mass examination of newborns that makes it possible to detect congenital and hereditary diseases at an early stage. Since 2023, expanded neonatal screening has been operating in Russia, including the diagnosis of 36 diseases. Objective. To evaluate the effectiveness of the extended neonatal screening program for newborns in the Penza region in 2023–2024. Materials and methods. Samples of the patients’ dry blood stains were used as the material. The diagnosis was carried out by tandem mass spectrometry, polymerase chain reaction, and immunofluorescence analysis. The predictive value indicator and the accurate Fisher test were used for statistical processing. Conclusion. Сalculating the accurate Fisher test and the negative prognostic value, it was found that the expanded neonatal screening program in the Penza Region for 2023–2024 is effective. Despite a low positive predictive value of the expanded neonatal screening, the negative predictive value was high — which offers a high probability of ruling out the condition in the event of a negative results. This underscores the primary role of this program within the early diagnostic system.

Authors

Institutions

Publication Details

Journal
Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Published
2026-11-16
DOI
https://doi.org/10.21508/1027-4065-2026-71-5(1)-93-97
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The effectiveness of expanded neonatal screening in the Penza Region in 2023–2024

Lyudmila I. Krasnova, Anastasia I. Marushkina, E. V. Shelkova, M. N. Maksimova et al.
2 links
Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Metabolism and Genetic Disorders
article

The effectiveness of expanded neonatal screening in the Penza Region in 2023–2024

Lyudmila I. Krasnova, Anastasia I. Marushkina, E. V. Shelkova, M. N. Maksimova, A. R. Dulina
article en

Abstract

Neonatal screening is a mass examination of newborns that makes it possible to detect congenital and hereditary diseases at an early stage. Since 2023, expanded neonatal screening has been operating in Russia, including the diagnosis of 36 diseases. Objective. To evaluate the effectiveness of the extended neonatal screening program for newborns in the Penza region in 2023–2024. Materials and methods. Samples of the patients’ dry blood stains were used as the material. The diagnosis was carried out by tandem mass spectrometry, polymerase chain reaction, and immunofluorescence analysis. The predictive value indicator and the accurate Fisher test were used for statistical processing. Conclusion. Сalculating the accurate Fisher test and the negative prognostic value, it was found that the expanded neonatal screening program in the Penza Region for 2023–2024 is effective. Despite a low positive predictive value of the expanded neonatal screening, the negative predictive value was high — which offers a high probability of ruling out the condition in the event of a negative results. This underscores the primary role of this program within the early diagnostic system.

Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)Vol. 71(5)
Penza State University (RU)
Good health and well-being
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon